C3G prevents and reverses the hypercholesterolemia-induced endothelial malfunction by suppressing the accumulation of cholesterol and the subsequent decrease in the production of hyperoxides in the aorta (1), thus maintaining eNOS activities and NO bio-availability. The gene discussed is NOS3; the disease is familial hypercholesterolemia.